Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Summary
Patients may benefit from the personalized β-lactams dosing strategy based on pharmacokinetics. The objective of this study is to retrospectively review, prospective observe and analyze the clinical outcomes of patients with liver cirrhosis, and to build a population pharmacokinetics model in the population mentioned above.
Official title: Clinical Efficacy and Population Pharmacokinetics of β-lactams in Patients With Liver Cirrhosis: A Retro-prospective Observational Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2023-12-31
Completion Date
2027-12-31
Last Updated
2026-05-28
Healthy Volunteers
No
Conditions
Interventions
β-lactams
Participants receiving β-lactams were included.
Locations (1)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China